Project Details
Description
KB407-02: A Phase 1 Study of Inhaled KB407, a Replication-Defective, Non-Integrating Vector Expressing Human Cystic Fibrosis Transmembrane Conductance Regulator, for the Treatment of Cystic Fibrosis
| Status | Active |
|---|---|
| Effective start/end date | 9/1/25 → 6/1/27 |
Funding
- KRYSTAL BIOTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.